Advances in the study of mesenchymal stem cells for end-stage liver disease
10.3760/cma.j.cn501113-20210610-00270
- VernacularTitle:间充质干细胞治疗终末期肝病的研究进展
- Author:
Yongyuan ZHENG
1
;
Shu ZHU
;
Liang PENG
;
Zhiliang GAO
Author Information
1. 中山大学第三临床学院，广州 510630
- Keywords:
End-stage liver disease;
Mesenchymal stem cell;
Immunoregulation;
Exosome
- From:
Chinese Journal of Hepatology
2021;29(7):618-621
- CountryChina
- Language:Chinese
-
Abstract:
End-stage liver disease refers to the advanced stage of liver disease caused by various chronic liver damage. Orthotopic liver transplantation is the most important final treatment option, but liver transplantation is still limited by many factors at present. Stem cell transplantation therapy has attracted widespread attention as a potential treatment for end-stage liver disease. This article reviews the research progress of mesenchymal stem cell therapy in end-stage liver disease.
